Clinical Trials in Pathum Wan, Thailand
6 recruiting
Showing 1–20 of 26 trials
Recruiting
Phase 1
A Study of BG-C477 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
BeOne Medicines310 enrolled52 locationsNCT06596473
Recruiting
Phase 3
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Head and Neck Squamous Cell Carcinoma
Merus B.V.700 enrolled205 locationsNCT06525220
Recruiting
Phase 2
Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV
Mild Neurocognitive DisorderMajor Depressive DisorderHIV
National Institute of Allergy and Infectious Diseases (NIAID)186 enrolled41 locationsNCT06705478
Recruiting
Phase 2
Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis
Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID)315 enrolled29 locationsNCT06192160
Recruiting
Phase 3
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
COVID19COVIDSARS-CoV2 infection
University of Minnesota820 enrolled66 locationsNCT04910269
Recruiting
Phase 3
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Ischemic Stroke; Ischemic Attack, Transient
Janssen Research & Development, LLC15,000 enrolled880 locationsNCT05702034
Recruiting
Phase 3
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
Hepatitis CHepatitis C, ChronicHepatitis C Virus Infection+1 more
Atea Pharmaceuticals, Inc.880 enrolled106 locationsNCT07037277
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Lung CancerEGFRNSCLC, Stage IB-IIIA+5 more
Taiho Oncology, Inc.360 enrolled253 locationsNCT07128199
Recruiting
Not Applicable
The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
Substance UseMental Health DisordersHIV Prevention+2 more
Institute of HIV Research and Innovation Foundation, Thailand140 enrolled1 locationNCT07512856
Recruiting
Not Applicable
Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engage in Chemsex or Substance Use in Thailand
Mental HealthSubstance UseHIV Prevention+2 more
Institute of HIV Research and Innovation Foundation, Thailand300 enrolled1 locationNCT07509853
Recruiting
Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Implementation Study
Mental HealthSubstance UseHIV Prevention+1 more
Institute of HIV Research and Innovation Foundation, Thailand76 enrolled1 locationNCT07512869
Recruiting
Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX
Substance UseHIV PreventionSexually Transmitted Infections (STIs)
Institute of HIV Research and Innovation Foundation, Thailand50 enrolled1 locationNCT07505875
Recruiting
Behavioral and Psychosocial Characteristics of Clients Accessing Services at IHRI
HIV
Institute of HIV Research and Innovation Foundation, Thailand300,000 enrolled1 locationNCT06741319
Recruiting
Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Gastric CancerGastroesophageal-junction Cancer
Daiichi Sankyo726 enrolled250 locationsNCT06731478
Recruiting
Phase 3
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Dimerix Bioscience Pty Ltd286 enrolled220 locationsNCT05183646
Recruiting
Phase 3
Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)
HIV Infections
ViiV Healthcare3,508 enrolled34 locationsNCT06134362
Recruiting
Phase 2
Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users
Uterine HemorrhageMenstruation DisturbancesContraception Behavior+1 more
Chulalongkorn University40 enrolled1 locationNCT07083635
Recruiting
Not Applicable
Thai PainPREDICT Validation Study
Type 1 Diabetes Mellitus (T1DM)Type 2 Diabetes Mellitus (T2DM)Neuropathic Pain+3 more
Chulalongkorn University277 enrolled1 locationNCT07195045
Recruiting
Phase 1
RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEV
HIV InfectionsARTAcute HIV Infection+1 more
Henry M. Jackson Foundation for the Advancement of Military Medicine48 enrolled1 locationNCT06484335
Recruiting
Amyotrophic Lateral Sclerosis Registry in Thailand
ALS (Amyotrophic Lateral Sclerosis)
Chulalongkorn University100 enrolled1 locationNCT07175935